| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/27/2009 | WO2008110552A3 An anti-diabetic extract of honeybush |
| 08/27/2009 | WO2008097861A3 MODULATION OF NEUROGENESIS WITH BIGUANIDES AND GSK3-ß AGENTS |
| 08/27/2009 | WO2008095093A3 Method of increasing cellular function and health of glutathione deficient animals |
| 08/27/2009 | WO2008038092A3 Substituted piperidinophenyl oxazolidinones |
| 08/27/2009 | WO2008026048A3 Stable injectable pharmaceutical compositions of docetaxel |
| 08/27/2009 | WO2008026044A3 Pharmaceutical compositions of bupropion |
| 08/27/2009 | WO2007125397A3 Compositions and methods for inhibiting gastric acidity using endoperoxide bridge-containing compounds |
| 08/27/2009 | WO2007079003A3 Amide inhibitors of leukotriene a4 hydrolase |
| 08/27/2009 | WO2007025254A3 Investigation and treatment of cancer using a g-protien coupled eicosnoid receptor |
| 08/27/2009 | WO2007003934A3 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors |
| 08/27/2009 | WO2006125227A3 Fibroblast activation protein inhibitor compounds and methods |
| 08/27/2009 | WO2006087393A3 Structural analogues of avenanthramides, their use in compositions useful in the treatment of dermatological disorders |
| 08/27/2009 | WO2003097854A3 Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals |
| 08/27/2009 | US20090217400 Enzymes, cells and methods for site specific recombination at asymmetric sites |
| 08/27/2009 | US20090217398 Methods to identify fat and lean animals using class predictors |
| 08/27/2009 | US20090216317 Delivery of Highly Lipophilic Agents Via Medical Devices |
| 08/27/2009 | US20090216023 e.g.2-(2-ethylsulfanyl-1-hydroxy-1-methyl-ethyl)-6-trifluoromethyl-(pyrimidine or pyridazine or piperazine)-pyrrole-5-carbonitrile; anticarcinogenic; prostate carcinoma, benign prostatic hyperplasia (BPH), hirsutism, alopecia, anorexia nervosa, breast cancer, acne, AIDS, cachexia, as a male contraceptive |
| 08/27/2009 | US20090216014 Novel compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 08/27/2009 | US20090216013 e.g.1,1-Dicyclohexyl-3-[5-(pyridin-2-ylsulfanyl)-thiazol-2-yl]-urea; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
| 08/27/2009 | US20090215908 Toll like receptor (tlr) signaling antagonist |
| 08/27/2009 | US20090215907 Dosing regimes for trans-clomiphene |
| 08/27/2009 | US20090215906 Methods and materials with trans-clomiphene for the treatment of male infertility |
| 08/27/2009 | US20090215905 Novel substituted aryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/27/2009 | US20090215904 Colchicine compositions and methods |
| 08/27/2009 | US20090215903 Injectable Liquid Paracetamol Formulation |
| 08/27/2009 | US20090215902 Methods for the treatment of dermatological disorders |
| 08/27/2009 | US20090215901 Methods for treatment of nocturia |
| 08/27/2009 | US20090215900 Composition and method for providing glutamine |
| 08/27/2009 | US20090215899 N-Phenyloxamide derivatives |
| 08/27/2009 | US20090215898 Tranexamic acid formulations |
| 08/27/2009 | US20090215897 Method for treatment and prevention of respiratory insufficiency |
| 08/27/2009 | US20090215896 Reelin deficiency or dysfunction and methods related thereto |
| 08/27/2009 | US20090215895 Therapeutic and carrier molecules |
| 08/27/2009 | US20090215894 Inhibition of phosphatase activity of soluble epoxide hydrolase amino terminus and uses thereof |
| 08/27/2009 | US20090215893 Parakeratosis inhibitor, pore-shrinking agent,or rough skin preventing/ameliorating agent, and external composition for skin |
| 08/27/2009 | US20090215892 Octanol Formulations and Methods of Treatment Using the Same |
| 08/27/2009 | US20090215891 S-[2-[(1-lminoethy)Amino]Ethyl]-2-Methyl-L-Cysteine Maleate Hydrochloride Crystalline Salt |
| 08/27/2009 | US20090215890 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 08/27/2009 | US20090215889 Novel Use of Zinc Gluconate for Treating Hydradenitis Suppurativa |
| 08/27/2009 | US20090215888 Topical nail formulation |
| 08/27/2009 | US20090215887 5-hydroxy-2-methyl-4h-pyran-4-one esters as novel tyrosinase inhibitors |
| 08/27/2009 | US20090215886 Anti-Inflammatory Formulation |
| 08/27/2009 | US20090215885 Antioxidant Food Composition and Methods and Uses Thereof |
| 08/27/2009 | US20090215884 Method for wound healing |
| 08/27/2009 | US20090215883 Pharmaceutical formulation comprising taxane, a solid composition of taxane, a process for preparing said solid composition of taxane, a solubilizing composition of said solid composition of taxane, and a kit for the injectable formulation of taxane |
| 08/27/2009 | US20090215882 Lyophilized solid taxane composition, a process for preparing said solid composition, a pharmaceutical formulation and a kit for said formulation |
| 08/27/2009 | US20090215881 Polyphenolic Bioprecursors |
| 08/27/2009 | US20090215880 Composition and Method for IN VIVO and IN VITRO Attenuation of Gene Expression Using Double Stranded RNA |
| 08/27/2009 | US20090215879 Methods and compositions for adeno-associated virus (aav) with hi loop mutations |
| 08/27/2009 | US20090215878 Treatment of chronic pain with zinc finger proteins |
| 08/27/2009 | US20090215877 Methods and Compositions for the Diagnosis and Treatment of Schizophrenia |
| 08/27/2009 | US20090215876 Mitotic Progression Genes and Methods of Modulating Mitosis |
| 08/27/2009 | US20090215875 Methods and kits for expanding hematopoietic stem cells |
| 08/27/2009 | US20090215874 Aptamers as agonists |
| 08/27/2009 | US20090215873 Therapeutic Molecules and their Uses |
| 08/27/2009 | US20090215872 Methods for Controlling Stem Cell Differentiation |
| 08/27/2009 | US20090215871 Simian adenovirus vectors and methods of use |
| 08/27/2009 | US20090215869 Hepatitis c virus non-structural ns3/4a fusion gene |
| 08/27/2009 | US20090215868 Therapeutic Medicament for Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Pulmonary Hypertension |
| 08/27/2009 | US20090215867 Cancer-Cell-Specific Cell Proliferation Inhibitors |
| 08/27/2009 | US20090215866 Akt ligands and polynucleotides encoding akt ligands |
| 08/27/2009 | US20090215865 Nucleic Acid Molecules and Collections Thereof, Their Application and Identification |
| 08/27/2009 | US20090215864 Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer |
| 08/27/2009 | US20090215863 Gene Silencing of Protease Activated Receptor 1(Par1) |
| 08/27/2009 | US20090215862 Micro rna |
| 08/27/2009 | US20090215861 Antisense oligonucleotides for treating allergy and neoplastic cell proliferation |
| 08/27/2009 | US20090215860 Compositions and methods for regulating gene transcription |
| 08/27/2009 | US20090215858 such as Pentylcarbamic acid 5-oxo-2,3,4,5-tetrahydrobenzo[b]thiepin-4-ylmethyl ester, having a high affinity for vanilloid receptors and/or cannabinoid receptors, used as analgesics or for the treatment of neuropathic pain |
| 08/27/2009 | US20090215857 Therapeutic Pyrrolidines |
| 08/27/2009 | US20090215856 Methods for monitoring IL-18 |
| 08/27/2009 | US20090215855 New Crystalline Atorvastatin Hemicalcium Salt Polymorph Form |
| 08/27/2009 | US20090215854 Antimicrobial compositions, products and methods employing same |
| 08/27/2009 | US20090215853 Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer |
| 08/27/2009 | US20090215852 Compositions and methods for ameliorating cachexia |
| 08/27/2009 | US20090215851 Method of Preparing a Porphyrin Derivative, a Porphyrin Derivative, Use of Said Porphyrin derivative and a pharmaceutical composition containing said porphyrin derivative |
| 08/27/2009 | US20090215850 Method for treating cb2 receptor mediated pain |
| 08/27/2009 | US20090215849 High stability aqueous gels comprising metronidazole and methods for the preparation thereof |
| 08/27/2009 | US20090215848 Novel imidazolidIn-2-one derivatives as selective androgen receptor modulators (SARMS) |
| 08/27/2009 | US20090215847 Tricyclic Angiotensin II Agonists |
| 08/27/2009 | US20090215846 (2,5-dioxoimidazolidin-i-yl)-n-hydroxy-acetamides as metalloproteinase inhibitors |
| 08/27/2009 | US20090215844 Compositions Comprising Nebivolol |
| 08/27/2009 | US20090215843 Tetrazole Derivatives and Their Use for the Treatment of Cardiovascular Diseases |
| 08/27/2009 | US20090215842 Method of Treating Schizophrenia Prodrome |
| 08/27/2009 | US20090215841 D2 Receptor Ligand-078 |
| 08/27/2009 | US20090215840 Methods for treating schizophrenia |
| 08/27/2009 | US20090215839 Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders |
| 08/27/2009 | US20090215838 Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use |
| 08/27/2009 | US20090215837 Administration of pyridinedicarboxylic acid compounds for stimulating or inducing the growth of human keratinous fibers and/or arresting their loss |
| 08/27/2009 | US20090215836 Roflumilast for the Treatment of Pulmonary Hypertension |
| 08/27/2009 | US20090215835 Treatment of cancer with sorafenib |
| 08/27/2009 | US20090215834 Heterocyclic inhibitors of mek and methods of use thereof |
| 08/27/2009 | US20090215833 Thermodynamically stable form of a tosylate salt |
| 08/27/2009 | US20090215831 Inhibitors of the gastric h+, k+-atpase with enhanced therapeutic properties |
| 08/27/2009 | US20090215830 Multiple ppi dosage form |
| 08/27/2009 | US20090215829 Thiophene carboxamides as inhibitors of the enzyme ikk-2 |
| 08/27/2009 | US20090215828 Substituted indole derivatives |
| 08/27/2009 | US20090215827 Inhibitors of cxcr2 |
| 08/27/2009 | US20090215826 Solid forms of a pyrrolidine-3,4-dicarboxamide derivative |
| 08/27/2009 | US20090215825 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 08/27/2009 | US20090215824 Indazole derivatives as inhibitors of hormone sensitive lipase |